Iambic Therapeutics Seeks $159.4 Million IPO Backed by Nvidia Amidst Positive Biotech Momentum
In a notable move within the biotechnology sector, Iambic Therapeutics has set its sights on raising up to $159.4 million in its upcoming Initial Public Offering (IPO), according to a...




